rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John Leite

Global Chief Commercial Off

Company insider

Files Form 4 as: Global Chief Commercial Off, Veracyte.

In numbers

Trades disclosed
43
Buys
0
Sells
12
Bought
$0
Sold
$3.1M
Companies
1
Companies where not an officer
0
First trade
2 Sep 2023
Last trade
21 Sep 2026
Last filed
22 Sep 2026

Companies traded

Where they are an officer
VCYT VeracyteOfficer · Diagnostics & Labs · last 21 Sep 20260 buys · 12 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 Sep 2026filed 22 Sep 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Sold$161K4,015 at $40.00filing
21 Sep 2026filed 22 Sep 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Sold$161K4,015 at $40.00filing
2 Sep 2026filed 4 Sep 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$178K3,961 at $44.88filing
2 Sep 2026filed 4 Sep 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$178K3,961 at $44.88filing
4 Jun 2026filed 4 Jun 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Sold$700K13,975 at $50.07filing
4 Jun 2026filed 4 Jun 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Sold$700K13,975 at $50.07filing
2 Jun 2026filed 4 Jun 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$194K4,059 at $47.80filing
2 Jun 2026filed 4 Jun 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$194K4,059 at $47.80filing
6 Mar 2026filed 10 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—36,181 at $0.00filing
6 Mar 2026filed 10 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—6,578 at $0.00filing
6 Mar 2026filed 10 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—36,181 at $0.00filing
6 Mar 2026filed 10 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—6,578 at $0.00filing
4 Mar 2026filed 6 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Sold$185K5,260 at $35.19filing
4 Mar 2026filed 6 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Sold$185K5,260 at $35.19filing
2 Mar 2026filed 4 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$271K7,517 at $36.01filing
2 Mar 2026filed 4 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$271K7,517 at $36.01filing
26 Feb 2026filed 2 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—47,149 at $0.00filing
26 Feb 2026filed 2 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$345K8,905 at $38.75filing
26 Feb 2026filed 2 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—47,149 at $0.00filing
26 Feb 2026filed 2 Mar 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code F$345K8,905 at $38.75filing

News

John Leite Sells 4,015 Shares of Veracyte (NASDAQ:VCYT) Stocktickerreport.com · 22 Sep 2026

1 headline in the last 90 days name John Leite; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care12

Buys in green, sells in red, by the company’s sector.

Related people

Jens HolsteinDirector · Director at Veracyte, filing Form 4 there in the last year
Annie McGuireEVP, General Counsel · EVP, General Counsel at Veracyte, filing Form 4 there in the last year
Marc StapleyChief Executive Officer · Chief Executive Officer at Veracyte, filing Form 4 there in the last year
Rebecca ChambersChief Financial Officer · Chief Financial Officer at Veracyte, filing Form 4 there in the last year
Phillip G. FebboChief Scientific & Med Officer · Chief Scientific & Med Officer at Veracyte, filing Form 4 there in the last year
Muna BhanjiDirector · Also traded VCYT in the last 90 days
Donald J. TrumpPresident · Also traded VCYT in the last 90 days